Pediatric ALL Panel: Karyotyping
N-Myc Oncogene Test USA - $226 DNA Analysis | FISH Testing for Cancer Detection N-Myc Oncogene Test Original price was: $300.Current price is: $226.
PIK3CA by NGS Test USA | $500 USD | Comprehensive Genetic Cancer Analysis | Next Generation Sequencing PIK3CA by NGS Original price was: $1,000.Current price is: $500.
Sale!

Pediatric ALL Panel: Karyotyping, MLPA Deletion/Duplication, and FISH Panel

Original price was: $800.Current price is: $600.

-25%

The Pediatric ALL Panel is a comprehensive genetic testing package designed specifically for diagnosing and characterizing acute lymphoblastic leukemia in children. This advanced panel combines three powerful genetic analysis techniques: conventional karyotyping to examine chromosome structure, MLPA (Multiplex Ligation-dependent Probe Amplification) for detecting specific gene deletions and duplications, and FISH (Fluorescence In Situ Hybridization) for identifying chromosomal abnormalities at the molecular level. This multi-faceted approach provides clinicians with crucial information about leukemia subtypes, prognosis, and potential treatment responses. The test requires a small blood or bone marrow sample and delivers results within 7-10 days. At only $600 USD, this comprehensive genetic analysis offers exceptional value for accurate leukemia diagnosis and management.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Pediatric ALL Panel: Comprehensive Genetic Analysis for Acute Lymphoblastic Leukemia

Understanding Pediatric Acute Lymphoblastic Leukemia Testing

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer, representing approximately 25% of all pediatric malignancies. The Pediatric ALL Panel represents a cutting-edge diagnostic approach that combines three essential genetic testing methodologies to provide comprehensive insights into leukemia characteristics, treatment response predictions, and long-term prognosis.

What This Comprehensive Panel Measures

The Pediatric ALL Panel integrates three sophisticated genetic analysis techniques:

  • Karyotyping: Examines chromosome structure and number to identify large-scale chromosomal abnormalities
  • MLPA Deletion/Duplication Analysis: Detects specific gene copy number variations and microdeletions
  • FISH Panel: Identifies specific chromosomal translocations and rearrangements at the molecular level

Clinical Importance and Applications

This comprehensive testing approach is crucial because genetic abnormalities in ALL significantly influence disease behavior, treatment response, and overall survival rates. The combination of these three methods provides a complete genetic profile that helps oncologists make informed treatment decisions and predict patient outcomes with greater accuracy.

Who Should Consider This Testing?

This panel is specifically recommended for:

  • Children newly diagnosed with suspected acute lymphoblastic leukemia
  • Patients with unexplained cytopenias or abnormal blood counts
  • Cases where bone marrow examination suggests lymphoid malignancy
  • Patients requiring comprehensive genetic profiling for treatment planning
  • Individuals with family history of hematological malignancies

Key Benefits of Comprehensive Genetic Testing

  • Accurate Diagnosis: Provides definitive confirmation of ALL subtype
  • Prognostic Stratification: Helps determine disease risk category and appropriate treatment intensity
  • Treatment Guidance: Identifies genetic markers that influence drug selection and response
  • Minimal Residual Disease Monitoring: Establishes baseline genetic markers for follow-up testing
  • Family Counseling: Provides information about potential hereditary factors

Understanding Your Test Results

Your comprehensive genetic report will include detailed information about:

  • Chromosomal Abnormalities: Identification of numerical and structural chromosome changes
  • Specific Genetic Alterations: Detection of common ALL-associated genetic changes
  • Risk Classification: Assignment to standard, high-risk, or very high-risk categories
  • Clinical Implications: Explanation of how genetic findings impact treatment decisions

All results are interpreted by board-certified genetic specialists and include clear explanations of clinical significance.

Test Pricing Information

Test Component Price
Discount Price $600 USD
Regular Price $800 USD

Test Specifications

  • Turnaround Time: 7-10 days
  • Sample Type: Peripheral Blood or Bone Marrow
  • Test Components: EDTA & Sodium Heparin Vacutainer (2-3 ml each)
  • Methodology: Cell culture + MLPA analysis

Convenient Testing Across the United States

We have diagnostic centers conveniently located throughout the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Take the Next Step Toward Accurate Diagnosis

Early and accurate genetic characterization of acute lymphoblastic leukemia is essential for optimal treatment outcomes. Our comprehensive Pediatric ALL Panel provides the detailed genetic information needed to guide personalized treatment strategies and improve patient prognosis.

Ready to schedule your genetic testing? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Our specialists are available to answer your questions and help you understand the testing process.

Note: This test requires a physician’s prescription for diagnostic purposes. Prescription requirements may not apply for surgical planning, pregnancy-related testing, or international travel documentation.

SKU: ef1f4d925a67 Category:

Related products